PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.\', \'Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.\', \'Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.\', \'Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Jon J van Rood Center for Clinical Transfusion Research, Sanquin/Leiden University Medical Center, Leiden, Netherlands.\', \'Department of Nephrology, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Munich, Germany.\', \'Erasmus Medical Centre, Rotterdam, Netherlands.\', \'Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.\', \'Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.\', \'Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/14651858.CD013825.pub2
?:doi
?:hasPublicationType
?:journal
  • The Cochrane database of systematic reviews
is ?:pmid of
?:pmid
?:pmid
  • 34473343
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all